342824-18-4

Upstream product

• 203514-18-5 ethyl 4-O-acetyl-2,6-di-O-benzoyl-1-thio-β-D-galactopyranoside 
• 170428-58-7 3-methoxy-2-pyridyl 2,3,4,6-tetra-O-benzyl-β-D-galactopyranoside 
• 166757-80-8 ((3aR,5R,7R,7aS)-5,7-dihydroxy-2,2-dimethylhexahydro-1,3-benzodioxol-5-yl)methyl 4-methylbenzenesulfonate 
• 101917-46-8 (3aS,4R,6R,7aR)-6-Hydroxymethyl-2,2-dimethyl-hexahydro-benzo[1,3]dioxole-4,6-diol 

Downstream Products

• 342824-32-2 (1R,2R,4S,6R)-4-Azidomethyl-6-[(2R,3R,4S,5S,6R)-3,5-dihydroxy-6-hydroxymethyl-4-((2R,3R,4S,5S,6R)-3,4,5-tris-benzyloxy-6-benzyloxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-2-yloxy]-cyclohexane-1,2,4-triol 
• 342824-31-1 C₆₃H₆₇N₃O₁₇ 

Relevant academic research and scientific papers

Synthesis of Gal determinant epitopes, their glycomimetic variants, and trimeric clusters - Relevance to tumor associated antigens and to discordant xenografts

The synthesis of Galα1→3Gal-quinic acid pseudo-trisaccharides and their elaboration into trimeric clusters is described.